Abstract
We investigated the effects of 5‐fluorouracil (5‐FU) on cell cycle‐regulating proteins in RPMI 4788 cells. 5‐FU inhibited cell growth dose‐dependently and this growth inhibition was accompanied with cell cycle accumulation in early S phase and increased expression of cyclin A. When cells were released from short‐term treatment (3 or 24 h) with 5‐FU, the cell cycle started to progress again and cyclin A protein levels decreased. Cyclin A‐associated kinase activity assay showed that cyclin A‐cyclin‐dependent kinase (Cdk) 2 kinase activity was altered by 5‐FU treatment concomitantly with the changes in cell cycle state seen in flow cytometric analysis. Furthermore, the elevation of cyclin A protein level by 5‐FU treatment was observed in three other human cancer cell lines, DLD‐1, H226Br and T.Tn. These results suggest that cyclin A protein levels in cancer cells are increased by 5‐FU, and the cyclin A function and degradation mechanism remain normal.
Keywords: 5‐FU, Cyclin A, Cell cycle, Exposure time
Full Text
The Full Text of this article is available as a PDF (513.9 KB).
REFERENCES
- 1).Bhuyan , B. K. , Blowers , C. L. , Neil , G. L. , Bono , V. H. and Day , K. J.Partial synchronization of L1210 cells by 5‐fluo‐rouracil and its use in drug combinations . Cancer Res. , 37 , 3204 – 3208 ( 1977. ). [PubMed] [Google Scholar]
- 2).Wheeler , G. P. , Bowdon , B. J. , Adamson , D. J. and Vail , M. H.Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. No.2 cells . Cancer Res. , 32 , 2661 – 2669 ( 1972. ). [PubMed] [Google Scholar]
- 3).Maybaum , J. , Ullman , B. , Mandel , H. G. , Day , J. L. and Sadee , W.Regulation of RNA‐ and DNA‐directed actions of 5‐fluoropyrimidines in mouse T‐lymphoma (S‐49) cells . Cancer Res. , 40 , 4209 – 215 ( 1980. ). [PubMed] [Google Scholar]
- 4).Lewin , F. , Skog , S. , Tribukait , B. and Ringborg , U.Effect of 5‐fluorouracil on the cell growth and cell cycle kinetics of a mouse ascites tumor growing in vivo . Acta Oncol. , 26 , 125 – 131 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 5).Sherr , C. J.Mammalian G1 cyclins . Cell , 73 , 1059 – 1065 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 6).Sherr , C. J.Cancer cell cycles . Science , 274 , 1672 – 1677 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 7).Hunter , T. and Pines , J.Cyclins and cancer II: Cyclin D and CDK inhibitors come of age . Cell , 79 , 573 – 582 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 8).Hunter , T. and Pines , J.Cyclins and cancer . Cell , 66 , 1071 – 1074 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 9).Moore , G. E. and Koike , A.Growth of human tumor cells in vitro and in vivo . Cancer , 17 , 11 – 20 ( 1964. ). [DOI] [PubMed] [Google Scholar]
- 10).Satomoto , K. , Haisa , M. , Naomoto , Y. , Tanaka , N. and Orita , K.Cyclin A and Cdk2 kinase activity are suppressed by combined treatment with tumor necrosis factor‐α and interferon‐α . Biochem. Biophys. Res. Commun. , 213 , 1115 – 1121 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 11).Duric' , V. , Lees , E. and Reed , S. I.Association of human cyclin E with a periodic G1‐S phase protein kinase . Science , 257 , 1958 – 1961 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 12).Kufe , D. W. , Major , P. P. , Egan , E. M. and Loh , E.5‐Flu‐oro‐2′‐deoxyuridine incorporation in L1210 DNA . J. Biol. Chem. , 256 , 8885 – 8888 ( 1981. ). [PubMed] [Google Scholar]
- 13).Myers , C. E.The pharmacology of the fluoropyrimidines . Pharmacol. Rev. , 33 , 1 – 15 ( 1981. ). [PubMed] [Google Scholar]
- 14).Fujii , S. , Shimamoto , Y. , Ohshimo , H. , Imaoka , T. , Motoyama , M. , Fukushima , M. and Shirasaka , T.Effects of the plasma concentration of 5‐fluorouracil and the duration of continuous venous infusion of 5‐fluorouracil with an inhibitor of 5‐fluorouracil degradation on Yoshida sarcomas in rats . Jpn. J. Cancer Res. , 80 , 167 – 172 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15).Sobrero , A. F. , Aschele , C. , Guglielmi , A. P. , Mori , A. M. , Melioli , G. G. , Rosso , R. and Bertino , J. R.Synergism and lack of cross‐resistance between short‐term and continuous exposure to fluorouracil in human colon adenocarcinoma cells . J. Natl. Cancer Inst. , 85 , 1937 – 1944 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 16).Inaba , M. and Mitsuhashi , J.Flow cytometric analysis of cell‐killing actions of 5‐fluorouracil in human colorectal cancer cells . Oncol. Res. , 6 , 303 – 309 ( 1994. ). [PubMed] [Google Scholar]
- 17).Pizzorno , G. , Sun , Z. and Handschumacher , R. E.Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5‐fluorouracil . Biochem. Pharmacol. , 49 , 553 – 557 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 18).Bui , K. C. , Wu , F. , Buckley , S. , Wu , L. , Williams , R. , Carbonaro‐Hall , D. , Hall , F. L. and Warburton , D.Cyclin A expression in normal and transformed alveolar epithelial cells . Am. J. Respir. Cell Mol. Biol. , 9 , 115 – 125 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 19).Juan , G. , Li , X. and Darzynkiewicz , Z.Correlation between DNA replication and expression of cyclin A and B1 in individual MOLT‐4 cells . Cancer Res. , 57 , 803 – 807 ( 1997. ). [PubMed] [Google Scholar]
- 20).Fang , F. and Newport , J. W.Evidence that the G1‐S and G2‐M transitions are controlled by different cdc2 proteins in higher eukaryotes . Cell , 66 , 731 – 742 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 21).Perit , E. , Milano , G. , Levi , F. , Thyss , A. , Bailleul , F. and Schneider , M.Circadian rhythm‐varying plasma concentration of 5‐fluorouracil during a five‐day continuous venous infusion at a constant rate in cancer patients . Cancer Res. , 48 , 1676 – 1679 ( 1988. ). [PubMed] [Google Scholar]